05/23/2022 | Press release | Distributed by Public on 05/23/2022 15:11
BOSTON - May 23, 2022 - GE Healthcare continues to experience temporary supply disruption for its iodinated contrast media products. After having to close our Shanghai manufacturing facility for several weeks due to local COVID policies, we have been able to reopen and are utilizing our other global plants wherever we can.
Our priority is delivering for our customers and their patients, and we are working around the clock to expand production and return to full capacity as soon as possible and in line with local authorities.
The company expects continued improvement over the coming weeks as a result of its actions to expand capacity, which include:
In a recent update, GE Healthcare shared how the situation is evolving daily and that the company is working closely with impacted customers to help them plan.
Customer Service, Sales and Medical Affairs teams are available to answer any questions.
For customer inquiries
For media inquiries
For investor inquiries
CAUTION CONCERNING FORWARD -LOOKING STATEMENTS:
This document contains "forward-looking statements" - that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain. For details on the uncertainties that may cause our actual future results to be materially different than those expressed in our forward-looking statements, see https://www.ge.com/investorrelations/important-forward-looking-statement-information as well as GE's annual reports on Form 10-K and quarterly reports on Form 10-Q. We do not undertake to update our forward-looking statements. This document also includes certain forward-looking projected financial information that is based on estimates and forecasts. Actual results could differ materially.